首页> 外文期刊>European journal of paediatric neurology: EJPN : official journal of the European Paediatric Neurology Society >Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: A randomised trial
【24h】

Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: A randomised trial

机译:静脉丙戊酸钠和苯巴比妥控制儿童癫痫持续状态和急性持续性惊厥发作的有效性和安全性:一项随机试验

获取原文
获取原文并翻译 | 示例
           

摘要

Status epilepticus and acute prolonged seizures are the most commonly occurring neurological emergencies in children. Such events have high morbidity and mortality rates along with poor long-term outcomes, depending on their duration and causes. Therefore, such seizures warrant urgent treatment using appropriate doses of anticonvulsants. Benzodiazepines, phenobarbital, and phenytoin are the most commonly used anticonvulsants for controlling status epilepticus and acute prolonged seizures. However, these medications have several well-known adverse effects. Previous studies on both adults and children have shown the efficacy and safety of rapid infusion of valproate in controlling status epilepticus. However, few well-designed randomised trials have been carried out in children, and there remains a paucity of data regarding intravenous sodium valproate use in children. Therefore, our aim was to compare the efficacy and safety of rapid loading of valproate with those of intravenous phenobarbital in children with status epilepticus and acute prolonged seizures. Sixty children (30 in each group) with convulsive status epilepticus and acute prolonged seizures were enrolled and randomly assigned to receive either valproate or phenobarbital. The main outcome variable was termination of all convulsive activity within 20 min of starting anticonvulsant infusion. Intravenous rapid loading of valproate was successful in seizure termination in (27/30, 90%) of patients compared to phenobarbital (23/30, 77%) (p = 0.189). Clinically significant adverse effects occurred in 74% patients of the phenobarbital group and 24% patients of the valproate group (p < 0.001). In conclusion, rapid loading of valproate is effective and safe in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children. Intravenous valproate should be considered as a suitable choice for terminating status epilepticus and acute prolonged seizures in children.
机译:癫痫持续状态和急性长时间发作是儿童中最常见的神经系统紧急情况。根据事件的持续时间和原因,此类事件的发病率和死亡率较高,远期结局也很差。因此,此类癫痫发作需要使用适当剂量的抗惊厥药紧急治疗。苯二氮卓类,苯巴比妥和苯妥英钠是最常用的抗惊厥药,用于控制癫痫持续状态和急性长时间发作。但是,这些药物有几种众所周知的副作用。先前对成人和儿童的研究均显示了快速输注丙戊酸盐在控制癫痫持续状态中的有效性和安全性。然而,很少有设计良好的随机试验在儿童中进行,关于儿童静脉使用丙戊酸钠的数据仍然很少。因此,我们的目的是比较快速加载丙戊酸盐和静脉苯巴比妥治疗癫痫持续状态和急性发作时间长的儿童的疗效和安全性。招募了60名儿童(每组30名)患有惊厥性癫痫发作和急性长时间发作,并随机分配接受丙戊酸盐或苯巴比妥治疗。主要结果变量是在开始抗惊厥输注后20分钟内终止所有惊厥活动。与苯巴比妥(23/30,77%)相比,静脉快速加载丙戊酸成功终止了癫痫发作的患者(27/30,90%)(p = 0.189)。临床显着的不良反应发生在苯巴比妥组的74%患者和丙戊酸盐组的24%患者中(p <0.001)。总之,快速加载丙戊酸盐在控制儿童惊厥性癫痫持续状态和急性长时间惊厥发作方面是安全有效的。丙戊酸静脉注射应被认为是终止儿童癫痫持续状态和急性长时间癫痫发作的合适选择。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号